Pharmaceutical companies offer a new prescription to keep the industry in good health. Hazem Sika speaks to Gustav Ando, Director of Life Sciences for IHS, and a specialist on mergers and acquisitions and Rohit Malpani, Director of Policy and Analysis for Doctors Without Borders' Access Campaign.
